{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:29:07Z","timestamp":1787869747731,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002869","name":"University of Kiel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.exphem.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T13:36:30Z","timestamp":1622813790000},"page":"54-64.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"99","author":[{"given":"Meike","family":"Kaehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Dworschak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Phillip","family":"Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ruemenapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5174-4454","authenticated-orcid":false,"given":"Inga","family":"Vater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-4286","authenticated-orcid":false,"given":"Eva Maria Murga","family":"Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2182-9534","authenticated-orcid":false,"given":"Ingolf","family":"Cascorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2021.05.006_bib0001","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1182\/blood-2011-07-347237","article-title":"AU-rich RNA binding proteins in hematopoiesis and leukemogenesis","volume":"118","author":"Baou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0002","article-title":"TIS11 family proteins and their roles in posttranscriptional gene regulation","volume":"2009","author":"Baou","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0003","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.1002\/wrna.1368","article-title":"Hallmarks of cancer and AU-rich elements","volume":"8","author":"Khabar","year":"2017","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.exphem.2021.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.cell.2018.06.001","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"173","author":"Martincorena","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2021.05.006_bib0005","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/sj.leu.2404739","article-title":"Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL","volume":"21","author":"Pospisilova","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.05.006_bib0006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.aad5978","article-title":"RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence","volume":"352","author":"Galloway","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.exphem.2021.05.006_bib0007","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.4049\/jimmunol.1600854","article-title":"The RNA-binding proteins Zfp36l1 and Zfp36l2 enforce the thymic beta-selection checkpoint by limiting DNA damage response signaling and cell cycle progression","volume":"197","author":"Vogel","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0008","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2021.05.006_bib0009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","article-title":"Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia","volume":"16","author":"Quintas-Cardama","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.exphem.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0011","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0012","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2021.05.006_bib0013","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia","volume":"15","author":"Milojkovic","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2021.05.006_bib0014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia","volume":"25","author":"Bixby","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2021.05.006_bib0016","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/cncr.28522","volume":"120","author":"Soverini","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2021.05.006_bib0017","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FPC.0b013e328350012b","article-title":"MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression","volume":"22","author":"Turrini","year":"2012","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.exphem.2021.05.006_bib0019","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0020","first-page":"822","article-title":"Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics","volume":"15","author":"Seigneurin","year":"1987","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0021","doi-asserted-by":"crossref","first-page":"92018","DOI":"10.18632\/oncotarget.21272","article-title":"MicroRNA-212\/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells","volume":"8","author":"Kaehler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2021.05.006_bib0022","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood-2009-09-240440","article-title":"Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies","volume":"116","author":"Nagel","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0023","first-page":"3114","article-title":"Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group","volume":"94","author":"Schlegelberger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0024","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1002\/jcb.27885","article-title":"Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells","volume":"120","author":"Waetzig","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2021.05.006_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/mol.119.116590","article-title":"Alternative polyadenylation of ABC transporters of the C-family (ABCC1, ABCC2, ABCC3) and implications on posttranscriptional micro-RNA regulation","volume":"97","author":"Bruhn","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0026","series-title":"An interactive tool for comparing lists with Venn's diagrams","author":"Oliveros","year":"2007-2015"},{"key":"10.1016\/j.exphem.2021.05.006_bib0027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbagrm.2017.12.006","article-title":"The AU-rich element landscape across human transcriptome reveals a large proportion in introns and regulation by ELAVL1\/HuR","volume":"1861","author":"Bakheet","year":"2018","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.exphem.2021.05.006_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/0008-5472.CAN-18-2796","article-title":"RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling","volume":"80","author":"Loh","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2021.05.006_bib0029","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni.1901","article-title":"Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia","volume":"11","author":"Hodson","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2009-04-214619","article-title":"Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis","volume":"114","author":"Stumpo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.05.006_bib0031","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1091\/mbc.e10-01-0040","article-title":"ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway","volume":"21","author":"Vignudelli","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.exphem.2021.05.006_bib0032","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.21133","article-title":"Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines","volume":"117","author":"Lee","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2021.05.006_bib0033","first-page":"25","article-title":"Mutation in the RNA binding protein TIS11D\/ZFP36L2 is associated with the pathogenesis of acute leukemia","volume":"38","author":"Iwanaga","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0034","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/leu.2008.340","article-title":"Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells","volume":"23","author":"Baou","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.05.006_bib0035","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1158\/0008-5472.CAN-08-4238","article-title":"The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis","volume":"69","author":"Brennan","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2021.05.006_bib0036","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.abb.2007.04.011","article-title":"Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines","volume":"462","author":"Carrick","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.exphem.2021.05.006_bib0037","doi-asserted-by":"crossref","first-page":"59144","DOI":"10.18632\/oncotarget.10828","article-title":"Loss of ZFP36 expression in colorectal cancer correlates to wnt\/\u03b2-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of ZEB1, SOX9 and MACC1","volume":"7","author":"Montorsi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2021.05.006_bib0038","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3324\/haematol.2018.204917","article-title":"Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumorsuppressor gene epigenetically regulated","volume":"104","author":"Martinez-Calle","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2021.05.006_bib0039","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","article-title":"mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype","volume":"17","author":"Herranz","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2021.05.006_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13395-018-0183-9","article-title":"The RNA-binding proteins Zfp36l1 and Zfp36l2 act redundantly in myogenesis","volume":"8","author":"Bye","year":"2018","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.exphem.2021.05.006_bib0041","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/s41598-018-21160-z","article-title":"ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner","volume":"8","author":"Suk","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2021.05.006_bib0042","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.exphem.2021.05.006_bib0043","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/cas.13990","article-title":"Hypoxia\/pseudohypoxia-mediated activation of hypoxia-inducible factor-1alpha in cancer","volume":"110","author":"Hayashi","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2021.05.006_bib0044","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/cancers11091220","article-title":"The multifaceted p21 (Cip1\/Waf1\/CDKN1A) in cell differentiation, migration and cancer therapy","volume":"11","author":"Kreis","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2021.05.006_bib0045","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cancers11081178","article-title":"p21 in cancer research","volume":"11","author":"Shamloo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2021.05.006_bib0046","doi-asserted-by":"crossref","first-page":"E1740","DOI":"10.1073\/pnas.1320873111","article-title":"Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase","volume":"111","author":"Tan","year":"2014","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:36:19Z","timestamp":1759566979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X21001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":46,"alternative-id":["S0301472X21001995"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2021.05.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}